| 摘要 |
The present invention relates to a new peptide with endotoxin-neutralizing activity which can be used for the preparation of a pharmaceutical composition for neutralizing lipopolysaccharide and particularly for the treatment of sepsis. The invention further relates to a diagnostic method for demonstrating the presence of endotoxin in blood or blood fractions, such as serum or plasma. |
